In the Press

 Investigated UR-GUV performance in airport bus, classroom and rehearsal room.

Emerging subvariants have hit on a combination of mutations that makes them more immune evasive than ever

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute and Roswell Park Comprehensive Cancer Center report in a new study published today by the New England Journal of Medicine.

A study today in Morbidity and Mortality Weekly Report shows that US nursing home residents who received a second mRNA COVID-19 vaccine booster dose 60 days earlier were 26% protected against Omicron infection, 74% against hospitalization or death, and 90% against death alone.

We have developed a deep learning aging clock using blood test data from the China Health and Retirement Longitudinal Study, which has a mean absolute error of 5.68 years.

The frequent emergence of coronavirus (CoV) epidemics has seriously threatened public health and stock farming.

The World Health Organization recommends ciprofloxacin (a fluoroquinolone) as a first-line treatment for shigellosis, and azithromycin (a macrolide), ceftriaxone (a third-generation cephalosporin), or pivmecillinam (an extended-spectrum penicillin) as second-line therapies (7). Isolates are classified as multidrug-resistant (MDR) (technical note C) or extensively drug-resistant (XDR) (technical note D) based on the presence of genetic markers of resistance.

On 16 September 2022, the Ministry of Health (MoH) of Ghana declared the end of the Marburg Virus Disease (MVD) outbreak that affected the country’s Ashanti, Savannah and Western regions. In accordance with WHO recommendations the declaration was made 42 days (twice the maximum incubation period for Marburg infection) after the second negative test of the last confirmed case on 5 August 2022.

Dietary supplements are touted for cognitive protection, but supporting evidence is mixed. COSMOS-Mind tested whether daily administration of cocoa extract (containing 500 mg/day flavanols) versus placebo and a commercial multivitamin-mineral (MVM) versus placebo improved cognition in older women and men.

Introduction Despite proven effectiveness for people with chronic respiratory diseases, practical barriers to attending centre-based pulmonary rehabilitation (centre-PR) limit accessibility. We aimed to review the clinical effectiveness, components and completion rates of home-based pulmonary rehabilitation (home-PR) compared to centre-PR or usual care.